News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

i3 (Basking Ridge, New Jersey) Launches New Web-Based Technology To Simplify And Accelerate The Clinical Trial Process



3/17/2009 2:44:01 PM

BASKING RIDGE, NJ, March 17, 2009—Pharmaceutical services company i3 today launched its innovative, web-based i3CubeTM clinical trial and data management technology. i3Cube leverages i3’s services and proprietary data to accelerate the clinical trial process through automation and connectivity, so that customers can make more rapid, informed decisions about their products throughout development and commercialization.

i3Cube replaces the need for multiple systems and applications to manage study activities with an integrated solution that centralizes study information into a single location throughout the entire clinical trial process. This technology gives sponsors and investigative site staff intuitive dashboards that deliver real-time reporting and access to study information – all in one place. Additionally, i3Cube provides greater speed and efficiencies through streamlined communication across the entire study team, study-specific automated workflow, and an integrated study library with version control, including an electronic trial master file.

i3Cube is a comprehensive solution built by clinical experts and powered by industry-leading design on a user-friendly Adobe® platform.

“i3Cube was designed to provide our clients and clinical investigators with a simple, easy-to-use, and streamlined experience,” said Glenn Bilawsky, CEO of i3. “We brought together our use of proprietary health care claims data with our clinical research expertise and developed i3Cube to create time and cost efficiencies for our customers.”

i3Cube provides a high level of study transparency that enables enhanced trial collaboration. By simply logging into a secure web portal, everyone involved in conducting and managing a trial is connected, keeping the entire study team aware of all activity at every point in the process.

“i3Cube integrates the management of all aspects of the clinical trial process, providing real-time visibility and enhancing the pace and efficiency of each step in ways no other e-clinical product can,” said Joe Tetzlaff, chief technology officer of i3.

About i3

i3, a global Ingenix company, provides integrated scientific strategies and solutions throughout the pharmaceutical product lifecycle. It is composed of i3 Research, a therapeutically specialized contract research organization; i3 Drug Safety, engaged in pharmacovigilance and epidemiology; i3 Pharma Informatics, a data, science and technology provider of market analytics; i3 Statprobe, a leader in comprehensive data services; i3 Pharma Resourcing, a world-class staffing partner; and i3 Innovus, delivering the science and solutions to achieve marketplace success. i3 helps companies gain sharper insights that lead to better patient care. For more information, visit www.i3global.com. Ingenix is a subsidiary of UnitedHealth Group (NYSE: UNH).


Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES